$ALT
Altimmune Inc

2012 Q4 Form 10-Q Financial Statement

#000114420412059795 Filed on November 06, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2011 Q3
Revenue $6.010M $6.700M $5.260M
YoY Change -3.69% 27.38% -15.71%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.620M $3.280M $3.280M
YoY Change -2.24% 0.0% 3.14%
% of Gross Profit
Research & Development $4.750M $5.139M $4.884M
YoY Change 4.86% 5.21% -20.84%
% of Gross Profit
Depreciation & Amortization $70.00K $72.45K $120.0K
YoY Change -36.36% -39.62% -53.85%
% of Gross Profit
Operating Expenses $7.440M $8.487M $8.282M
YoY Change 1.64% 2.47% -13.82%
Operating Profit -$1.427M -$1.790M -$3.022M
YoY Change 31.83% -40.75%
Interest Expense $140.0K $112.5K $9.932K
YoY Change -86.79% 1032.99% -101.14%
% of Operating Profit
Other Income/Expense, Net $30.00K $1.599M $2.988M
YoY Change -400.0% -46.51% -3420.46%
Pretax Income -$1.260M -$191.9K -$33.50K
YoY Change -268.0% 472.8% -99.23%
Income Tax $10.00K $22.07K $0.00
% Of Pretax Income
Net Earnings -$1.270M -$213.9K -$33.50K
YoY Change -269.48% 538.69% -99.23%
Net Earnings / Revenue -21.13% -3.19% -0.64%
Basic Earnings Per Share -$0.03 $0.00 $0.00
Diluted Earnings Per Share -$0.03 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 48.37M shares 48.37M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q4 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.70M $14.70M $10.40M
YoY Change 13.39% 41.35% 285.19%
Cash & Equivalents $12.70M $14.73M $10.41M
Short-Term Investments
Other Short-Term Assets $500.0K $400.0K $1.600M
YoY Change -44.44% -75.0% 77.78%
Inventory
Prepaid Expenses
Receivables $6.500M $5.300M $6.400M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $19.80M $20.38M $18.30M
YoY Change 0.93% 11.36% 48.78%
LONG-TERM ASSETS
Property, Plant & Equipment $484.0K $553.1K $900.0K
YoY Change -38.63% -38.55% -85.0%
Goodwill $2.348M $2.348M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $113.1K $130.7K $100.0K
YoY Change 111.92% 30.71% 0.0%
Total Long-Term Assets $2.946M $3.032M $3.300M
YoY Change -7.68% -8.11% -64.52%
TOTAL ASSETS
Total Short-Term Assets $19.80M $20.38M $18.30M
Total Long-Term Assets $2.946M $3.032M $3.300M
Total Assets $22.74M $23.41M $21.60M
YoY Change -0.27% 8.38% 0.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.697M $1.847M $400.0K
YoY Change 17.4% 361.65% -94.03%
Accrued Expenses $2.300M $3.200M $3.200M
YoY Change -14.81% 0.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $1.331M $1.208M $0.00
YoY Change
Long-Term Debt Due $750.0K $681.8K
YoY Change
Total Short-Term Liabilities $7.488M $6.971M $3.700M
YoY Change 62.25% 88.39% -87.67%
LONG-TERM LIABILITIES
Long-Term Debt $1.704M $1.764M $0.00
YoY Change
Other Long-Term Liabilities $579.4K $579.7K $3.400M
YoY Change 28.84% -82.95% 13.33%
Total Long-Term Liabilities $2.284M $2.344M $3.400M
YoY Change 407.78% -31.06% 13.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.488M $6.971M $3.700M
Total Long-Term Liabilities $2.284M $2.344M $3.400M
Total Liabilities $11.07M $10.86M $7.100M
YoY Change 59.21% 52.96% -78.48%
SHAREHOLDERS EQUITY
Retained Earnings -$198.6M -$197.3M
YoY Change 2.54%
Common Stock $210.5M $210.1M
YoY Change 0.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.67M $12.55M $14.50M
YoY Change
Total Liabilities & Shareholders Equity $22.74M $23.41M $21.60M
YoY Change -0.27% 8.38% 0.0%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income -$1.270M -$213.9K -$33.50K
YoY Change -269.48% 538.69% -99.23%
Depreciation, Depletion And Amortization $70.00K $72.45K $120.0K
YoY Change -36.36% -39.62% -53.85%
Cash From Operating Activities -$2.140M $1.730M -$3.610M
YoY Change 164.2% -147.92% 131.41%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$40.00K
YoY Change -100.0% -300.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 -$40.00K
YoY Change -100.0% -100.0% -500.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 120.0K 1.210M -50.00K
YoY Change 300.0% -2520.0% -101.44%
NET CHANGE
Cash From Operating Activities -2.140M 1.730M -3.610M
Cash From Investing Activities 0.000 0.000 -40.00K
Cash From Financing Activities 120.0K 1.210M -50.00K
Net Change In Cash -2.020M 2.940M -3.700M
YoY Change -306.12% -179.46% -292.71%
FREE CASH FLOW
Cash From Operating Activities -$2.140M $1.730M -$3.610M
Capital Expenditures $0.00 $0.00 -$40.00K
Free Cash Flow -$2.140M $1.730M -$3.570M
YoY Change 164.2% -148.46% 125.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48365984 shares
CY2012Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
46584 shares
CY2012Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.61
CY2012Q1 pip Warrant Expiration Date
WarrantExpirationDate
2022-03-30
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10406076
CY2012Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
363742
CY2012Q3 us-gaap Goodwill
Goodwill
2348453
CY2012Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
69876
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
210101716
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
130709
CY2012Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
909096
CY2012Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
1208370
CY2012Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
12550750
CY2012Q3 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.1014 pure
CY2012Q3 us-gaap Short Term Debt Percentage Bearing Variable Interest Rate
ShortTermDebtPercentageBearingVariableInterestRate
0.015 pure
CY2012Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2500000
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-215977
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q3 us-gaap Billed Contract Receivables
BilledContractReceivables
1606241
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48345984 shares
CY2012Q3 us-gaap Liabilities
Liabilities
10860115
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1846614
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
579707
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-197339824
CY2012Q3 us-gaap Assets
Assets
23410865
CY2012Q3 us-gaap Long Term Debt
LongTermDebt
2500000
CY2012Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3682311
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23410865
CY2012Q3 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
216000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14726328
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48345984 shares
CY2012Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
46584 shares
CY2012Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
909096
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6970610
CY2012Q3 us-gaap Deferred Revenue
DeferredRevenue
46000
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
4835
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
681808
CY2012Q3 us-gaap Assets Current
AssetsCurrent
20378622
CY2012Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1545534
CY2012Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.61
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
553081
CY2012Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
681822
CY2012Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1764264
CY2012Q3 pip Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3233804
CY2012Q3 pip Warrant Expiration Date
WarrantExpirationDate
2022-03-30
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11785327
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
830585
CY2011Q4 us-gaap Goodwill
Goodwill
2348453
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
208525917
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53384
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
15851806
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
1010522
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
4424442
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100000
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48236172 shares
CY2011Q4 us-gaap Liabilities
Liabilities
6951703
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1445700
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
449709
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-193689457
CY2011Q4 us-gaap Assets
Assets
22803509
CY2011Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3021208
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22803509
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11236771
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48236172 shares
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4615342
CY2011Q4 us-gaap Assets Current
AssetsCurrent
19613006
CY2011Q4 us-gaap Deferred Revenue
DeferredRevenue
500000
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
4824
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Interest Expense
InterestExpense
40540
pip Provision And Recovery For Doubtful Accounts
ProvisionAndRecoveryForDoubtfulAccounts
-8168
pip Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsGrantedInPeriod
50000 shares
pip Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
5814639
dei Trading Symbol
TradingSymbol
PIP
dei Entity Registrant Name
EntityRegistrantName
PHARMATHENE, INC
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10900000 shares
us-gaap Net Income Loss
NetIncomeLoss
-4546766
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5750277
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6096403
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
560639 shares
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-54668
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
400000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
6075555
us-gaap Operating Expenses
OperatingExpenses
28669788
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
204291
CY2011Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1886652
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
788666
CY2011Q4 pip Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3169642
us-gaap Operating Income Loss
OperatingIncomeLoss
-10643169
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2684507
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
50892
us-gaap Contracts Revenue
ContractsRevenue
18026619
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4635643
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-64362
us-gaap Share Based Compensation
ShareBasedCompensation
1881416
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-1357711
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Depreciation And Amortization
DepreciationAndAmortization
348813
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7003421
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-71439
us-gaap Investment Income Interest
InvestmentIncomeInterest
10496
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
71439
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1379251
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11632272
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1439312
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1080032
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-88877
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4546766
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16688703
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1881416
us-gaap Interest Paid
InterestPaid
40540
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47041027 shares
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001326190
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.065 pure
us-gaap Operating Income Loss
OperatingIncomeLoss
-4839277
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
216460
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
400764
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22122
us-gaap Contracts Revenue
ContractsRevenue
19162176
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4876866
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-32960
us-gaap Share Based Compensation
ShareBasedCompensation
1499910
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
67400
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
661103
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Depreciation And Amortization
DepreciationAndAmortization
234811
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-177864
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
67400
us-gaap Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
Payments on the term loan are interest-only for the first 10 months, which may be extended to 12 months if certain conditions described in the Loan Agreement are met. Subsequently, the term loan will fully amortize over its remaining term.
us-gaap Investment Income Interest
InvestmentIncomeInterest
13534
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1208370
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
100000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidationBeforeTax
-1227656
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3489557
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9004008
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-557683
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2818201
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1157
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3461757
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14762634
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3597934
us-gaap Operating Expenses
OperatingExpenses
24001453
us-gaap Paid In Kind Interest
PaidInKindInterest
81252
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-12225
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
66626
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1499910
us-gaap Interest Paid
InterestPaid
145658
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48314058 shares
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
188610
us-gaap Net Income Loss
NetIncomeLoss
-3650367
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1377520
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
200948 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
188610
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2087
us-gaap Use Of Estimates
UseOfEstimates
<div style="FONT: 10pt Times New Roman, Times, Serif"> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"><i>Use of Estimates</i></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#xA0;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.&#xA0;&#xA0;Actual results could differ from those estimates.</p> </div>
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-33496
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
1100000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
341118
us-gaap Interest Expense
InterestExpense
226910
pip Supplemental Warrant Issued In Connection With Long Term Debt
SupplementalWarrantIssuedInConnectionWithLongTermDebt
69876
pip Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsGrantedInPeriod
0 shares
pip Debt Instruments Maturity Date Month And Year
DebtInstrumentsMaturityDateMonthAndYear
2015-09
pip Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
38984
pip Proceeds From Issuance Of Long Term Debt And Warrants
ProceedsFromIssuanceOfLongTermDebtAndWarrants
2500000
pip Other Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation
OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation
1227656
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3021914
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
95520
CY2011Q3 us-gaap Contracts Revenue
ContractsRevenue
5260057
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-113081
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2011Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
114494
CY2011Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3961
CY2011Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3283246
CY2011Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-79585
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4884231
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
8281971
CY2011Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
626091
CY2011Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48194035 shares
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-33496
CY2011Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2988418
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
256639 shares
CY2011Q3 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
100000
CY2011Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
2898869
CY2011Q3 us-gaap Interest Expense
InterestExpense
9932
CY2011Q3 pip Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsGrantedInPeriod
50000 shares
CY2011Q3 pip Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Annual Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate
0.12 pure
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1790377
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-31312
CY2012Q3 us-gaap Contracts Revenue
ContractsRevenue
6696126
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1433902
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2012Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
72453
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
5727
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidationBeforeTax
-1227656
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3275428
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7690
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-191864
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5138622
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
8486503
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
439205
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48345984 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11500000 shares
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-213936
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1598513
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22072
CY2012Q3 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
100000
CY2012Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
508971
CY2012Q3 us-gaap Interest Expense
InterestExpense
112529
CY2012Q3 pip Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsGrantedInPeriod
0 shares
CY2012Q3 pip Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Annual Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate
0.12 pure
CY2012Q3 pip Other Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation
OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation
1227656

Files In Submission

Name View Source Status
0001144204-12-059795-index-headers.html Edgar Link pending
0001144204-12-059795-index.html Edgar Link pending
0001144204-12-059795.txt Edgar Link pending
0001144204-12-059795-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
pip-20120930.xml Edgar Link completed
pip-20120930.xsd Edgar Link pending
pip-20120930_cal.xml Edgar Link unprocessable
pip-20120930_def.xml Edgar Link unprocessable
pip-20120930_lab.xml Edgar Link unprocessable
pip-20120930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v324923_10q.htm Edgar Link pending
v324923_ex31-1.htm Edgar Link pending
v324923_ex31-2.htm Edgar Link pending
v324923_ex32-1.htm Edgar Link pending
v324923_ex32-2.htm Edgar Link pending